Relugolix is a gonadotropin-releasing hormone antagonist that induces a menopause-like state, reducing severe fibroid-related menstrual symptoms. In combination with estradiol and norethisterone, menopausal symptoms, bone-density loss and endometrial hyperplasia are limited.
No takes yet. Share an insight, caveat, or question.
NULL AUTHOR_ID (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: